Re:Cognition Health is acknowledged as a leading UK independent provider of cognitive health services. We provide early, accurate, diagnosis and treatment of cognitive disorders affecting individuals, of all ages, suffering from cognitive impairment as a consequence of a wide range of clinical conditions. Re:Cognition Health’s clinical trials centres in London, Guildford and Plymouth, offer those, who are clinically eligible, early access to new medications designed to slow down or halt progression of MCI, mild and moderate memory loss due to Alzheimer’s Disease
Our patients choose us because we are highly patient-centric, collaborative and effective, providing the most accurate diagnosis available and access to new and emerging treatments. Re:Cognition Health’s Birmingham centre is on schedule to open in summer 2017.
03/04/2026
A major study found that people who stay mentally active throughout life have a lower risk of developing dementia. Activities such as reading, writing, and learning languages were linked to up to a 40% lower risk of Alzheimer’s disease and mild cognitive impairment.
Lifelong mental stimulation was also associated with a later onset of dementia, highlighting its role in long-term brain health.
Autism acceptance focuses on understanding, inclusion, and recognising individual strengths and differences.
Listening, learning, and creating supportive environments help people on the autism spectrum feel respected and understood across all stages of life.
01/04/2026
The impact of trauma does not always end with physical recovery. Blast injuries can be followed by psychological effects that influence mood, memory, sleep, and daily functioning.
Improving recognition and diagnosis of PTSD helps ensure individuals receive the care and support they need to recover and move forward.
Neurodiversity recognises that there is no single way for a brain to think, learn, or process the world.
Autism and ADHD are part of natural neurological variation. Accurate assessment, understanding, and appropriate support help individuals thrive at every stage of life.
Neurodiversity Celebration Week encourages awareness, inclusion, and informed care.
18/03/2026
ADHD is often associated with inattention or hyperactivity, but many challenges are less visible.
Difficulties with emotional regulation, time perception, executive functioning, and sleep can significantly affect daily life. Recognising these hidden symptoms supports clearer understanding, accurate assessment, and access to the right support.
Brain Awareness Week focuses on increasing understanding of how the brain works and how neurological and cognitive conditions develop.
Advances in neuroscience research and diagnostics help provide clearer answers, support earlier identification, and guide more personalised care for patients and families.
Greater understanding of the brain leads to better outcomes across the lifespan.
16/03/2026
“Our brains are dying before our bodies.”
Have you watched Dr Emer MacSweeney’s latest TEDx talk yet?
In “A Breakthrough in Treating Degenerative Brain Diseases,” Re:Cognition Health's Co-Founder & CEO explores a new way of understanding conditions such as Alzheimer’s disease and CTE, and the scientific breakthroughs that could help shape the future of brain health. Thank you for this opportunity, TEDx !
In case you missed it: Dr Emer MacSweeney’s second TEDx talk is now live.
Dr MacSweeney shares the stories of two people whose lives were tragically cut short by degenerative brain disease, despite their bodies remaining strong and healthy.
Her talk explores a groundbreaking way of understanding how our brains work, why diseases like Alzheimer’s and Chronic Traumatic Encephalopathy (CTE) develop, and how emerging treatments may help change the future for millions of people worldwide.
A special thank you to TEDx for the opportunity to share this important conversation.
Re:Cognition Health has also established The Brain and Mind Foundation, dedicated to accelerating progress in brain health and ensuring our brains can live as long as our bodies. Learn more: https://thebrainandmindfoundation.org/
13/03/2026
Sleep supports memory, attention, mood, and overall brain health.
Research continues to show that poor sleep can affect cognitive performance and may influence long-term brain health. While many factors shape cognition, developing healthy sleep routines is an important foundation for wellbeing at every age.
13/03/2026
Sleep plays a vital role in how the brain functions and maintains itself.
Growing evidence suggests that disrupted sleep may affect the brain’s ability to clear waste, including proteins linked to dementia risk. Research into sleep and the brain continues to strengthen understanding of why good sleep matters for long-term cognitive health.
World Sleep Day highlights the importance of healthy sleep as part of overall brain wellbeing.
11/03/2026
We are proud to announce that Dr Emer MacSweeney, Co-Founder and CEO of Re:Cognition Health, has been named to Inc.’s 2026 Female Founders 500 list, recognising the most dynamic and innovative women entrepreneurs in the United States.
The annual list honours founders whose bold ideas, resilience, and leadership are shaping the future of their industries.
Under Dr MacSweeney’s leadership, Re:Cognition Health has helped translate groundbreaking Alzheimer’s research into real-world impact — bringing new amyloid-targeting therapies from clinical trials to patients and expanding access to earlier diagnosis and treatment.
This recognition highlights the growing global importance of advancing brain health and tackling diseases such as Alzheimer’s earlier than ever before. Thank you, Inc. Magazine!
11/03/2026
A supportive setting can make a meaningful difference during assessments.
We are committed to creating spaces that feel calm, accessible, and well equipped, alongside clinical care that is thorough, accurate, and compassionate.
Be the first to know and let us send you an email when Re:Cognition Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Re:Cognition Health specialise in the diagnosis, treatment and care of people experiencing cognitive and mental health concerns.
The Re:Cognition Health UK clinics in London, Guildford, Plymouth and Birmingham are global-leaders in clinical trial patient recruitment. The team are united by a shared vision to change the future of Alzheimer’s research by providing early access to new treatments for the disease, at no cost.
Re:Cognition Health’s first clinic in the USA opened in February 2018 in Fairfax, VA. The US team are committed to raising awareness of the opportunity for members of the local community to access disease-modifying treatments for Alzheimer’s disease, as part of a ground-breaking clinical trial.
The specialist mental health services provided at Re:Cognition Health’s Harley Street Medical Area Clinic include: ADHD assessments for children and adults, autism assessments, diagnostic and rehabilitation services for patients with mild traumatic brain injury and world-leading memory services.
Re:Cognition Health’s clinics are home to a range of brain & mind experts, including: Neurologists, Neuropsychiatrists, Neuroradiologists, Neuropsychologists, Speech & Language Therapists, Child & Adolescent Psychiatrists, Psychologists, Psychiatrists, Nutritionists and Physiotherapists.
